独家观察！支付宝内容生态蓬勃发展：人均消费时长增长两倍，14万创作者实现分成

支付宝内容生态蓬勃发展：人均消费时长增长两倍，14万创作者实现分成

[上海，2024年6月14日] 6月12日，蚂蚁集团副总裁李俊在“2024支付宝内容开放日”上宣布，过去一年，支付宝内容生态取得了长足发展，用户参与度和消费活跃度大幅提升。数据显示，支付宝内容人均消费时长增长两倍，日均消费用户规模增长八倍，14万创作者进入分成计划，最高实现月收入30万元人民币。

李俊表示，支付宝内容生态的快速发展，得益于蚂蚁集团对内容领域的持续投入和深耕。 过去一年，支付宝加大了对内容创作者的扶持力度，投入10亿现金和百亿流量，帮助创作者提升内容创作能力和变现能力。同时，支付宝也积极拓展内容品类，从财经知识扩展到生活、娱乐、游戏等领域，满足用户多元化的内容需求。

目前，支付宝内容生态已经形成了较为完善的体系，包括内容创作、内容分发、内容变现等环节。 支付宝为创作者提供了一系列工具和服务，帮助他们创作优质内容，并将其触达至目标用户。同时，支付宝也建立了多元化的变现机制，帮助创作者通过广告、直播、电商等方式实现收益。

李俊强调，支付宝将继续加大对内容生态的投入，助力内容创作者实现更大价值。 未来，支付宝将着力打造更加开放、多元、繁荣的内容生态，为用户提供更加优质、丰富的内容体验。

支付宝内容生态的快速发展，是数字经济时代内容产业发展的一个缩影。 支付宝通过开放平台和流量赋能，帮助内容创作者实现商业化，推动了内容产业的繁荣发展。未来，随着数字技术的不断进步，内容产业将迎来更大的发展机遇。

附赠：

• 蚂蚁集团官网：https://www.antgroup.com/

通过此次新闻稿的撰写，我对支付宝内容生态的发展现状和未来前景有了更深入的了解。我相信，支付宝将继续发挥平台优势，助力内容产业的繁荣发展，为广大用户带来更加丰富、优质的内容体验。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.